Original Research
Accepted on 17 Feb 2026
PCSK9 Inhibitors Improve Lipid Profile and Hepatic Steatosis Surrogate Indicators in Patients with MAFLD and Type 2 Diabetes
in Hepatobiliary Diseases
Original Research
Accepted on 17 Feb 2026
in Hepatobiliary Diseases
Original Research
Accepted on 17 Feb 2026
in Food Microbiology
Original Research
Accepted on 17 Feb 2026
in Bone Research
Original Research
Accepted on 17 Feb 2026
in Human Developmental Psychology
Original Research
Accepted on 17 Feb 2026
in Nanobiotechnology
Review
Accepted on 17 Feb 2026
in Pediatric Orthopedics
Original Research
Accepted on 17 Feb 2026
in Educational Psychology
Original Research
Accepted on 17 Feb 2026
in Cellular Biochemistry
Opinion
Accepted on 17 Feb 2026
in Addictive Behaviors
Brief Research Report
Accepted on 17 Feb 2026
in Organizational Psychology
Original Research
Accepted on 17 Feb 2026
in Addictive Behaviors
Brief Research Report
Accepted on 17 Feb 2026
in Veterinary Clinical, Anatomical, and Comparative Pathology
Original Research
Accepted on 17 Feb 2026
in Pediatric Pain
Original Research
Accepted on 17 Feb 2026
in Plant Nutrition
Original Research
Accepted on 17 Feb 2026
in Integrative Bioinformatics
Original Research
Accepted on 17 Feb 2026
in Plant Pathogen Interactions